Four drug firms agree to pay $26bn in proposed US opioid settlement

NEW YORK: Prosecutors from several US states on Wednesday unveiled a sweeping proposed settlement under which four pharmaceutical companies accused of fueling the country's opioid epidemic would pay up to $26 billion to resolve thousands of claims in federal and state courts.